Amgen Inc. (AMGN) – Market Context and Performance Overview
Market Performance on 2026‑10‑07
On Wednesday, October 7, 2026, the Nasdaq‑listed Amgen Inc. (ticker: AMGN) traded within a broader market environment that was marked by modest declines across major indices.
- Nasdaq‑100: The index closed 0.21 % lower at 31 160.08 points, after opening with a loss of 0.796 %.
- Dow Jones Industrial Average: This index finished 0.66 % lower at 51 179.87 points, following an initial decline of 0.79 % earlier in the session.
- S&P 500: The index finished the day with a 0.22 % loss, after a 1.06 % gain in the healthcare sector.
These movements reflect a generally cautious trading day in New York, with technology and industrial sectors contributing to the overall downturn.
Amgen’s Position within the Healthcare Sector
Amgen, a biotechnology firm specializing in innovative human therapeutics, is a component of the healthcare segment of the S&P 500. On the day in question, the healthcare sector recorded a 1.06 % gain, indicating that, despite broader market weakness, the sector remained resilient. While no specific intra‑day price data for Amgen is provided in the input, the company’s share price on 2026‑10‑06 closed at USD 413.08.
Company Fundamentals (as of 2026‑10‑06)
| Metric | Value |
|---|---|
| Market Capitalization | USD 217.66 bn |
| 52‑Week High | USD 447.03 (2026‑08‑24) |
| 52‑Week Low | USD 288.00 (2025‑10‑30) |
| Price‑Earnings Ratio | 24.97 |
| Currency | USD |
| Primary Exchange | Nasdaq |
| Industry | Biotechnology (Health Care) |
These fundamentals suggest that Amgen remains a large‑cap, well‑capitalized player within the biotechnology space, with a valuation that is moderate relative to its earnings.
Summary
During a day of overall market softness in New York, the healthcare sector showed modest strength, and Amgen’s share price continued to trade within its established 52‑week range. The company’s strong market capitalization and stable price‑to‑earnings ratio position it as a significant contributor to the biotechnology segment of the Nasdaq‑100 and the broader S&P 500.
